Aflac's net earnings went from $29 million to $1,019 million and diluted EPS from $0.05 to $1.98 — but the underlying insurance business earned almost exactly what it earned a year ago. Pretax adjusted earnings, the measure the company's own CODM uses to run the segments, came in at $1,122 million against $1,123 million in Q1 2025: flat to within a rounding error. The entire headline swing is the reversal of a $963 million net investment loss booked in the prior-year quarter into a $49 million gain this quarter, a $1,012 million mark-to-market whipsaw that says more about rates and the yen than about underwriting. What the quarter actually reveals is a supplemental insurer whose premium base keeps shrinking while its per-share numbers keep rising — because management is retiring shares faster than the book runs off.
- Consolidated Balance Sheet
1-1. Asset composition
| Item | Dec 31, 2025 ($M) | Mar 31, 2026 ($M) | Change % |
|------|------------|------------|--------|
| Cash and cash equivalents | 6,245 | 5,654 | -9.5% |
| Fixed maturity AFS (incl. consolidated VIEs) | 64,121 | 63,228 | -1.4% |
| Fixed maturity held-to-maturity | 16,120 | 15,752 | -2.3% |
| Equity securities | 887 | 851 | -4.1% |
| Commercial mortgage and other loans, net | 9,765 | 9,770 | +0.1% |
| Other investments | 6,622 | 7,937 | +19.9% |
| Total investments and cash | 103,760 | 103,192 | -0.5% |
| Deferred policy acquisition costs | 9,034 | 8,976 | -0.6% |
| Total assets | 116,470 | 116,280 | -0.2% |
The balance sheet barely moved in aggregate, but the composition inside it did. The single largest mover was "other investments," up 19.9% to $7,937 million — a $1,315 million reallocation that lines up with the $1,321 million of net cash the company put into that bucket in the investing section of the cash flow statement. Against that, the traditional bond book shrank: available-for-sale fixed maturities fell 1.4% and held-to-maturity 2.3%. This is Aflac moving money down the liquidity curve in search of yield.
The unrealized position deserves attention. AFS fixed maturities carry an amortized cost of $62,711 million against fair value of $59,683 million — the portfolio is $3,028 million underwater, versus $1,959 million underwater at year-end. The held-to-maturity book, carried at amortized cost of $15,752 million, has a fair value of $14,769 million, an unrecognized $983 million loss that never touches equity. Combined, roughly $3.2 billion of unrealized investment losses sit either in AOCI or entirely off the income statement — $2,228 million across the full AFS book (the consolidated-VIE portion is still $800 million in the money) plus $983 million of unrecognized HTM loss. That figure grew about $1.4 billion in a single quarter.
What keeps equity intact is the offsetting liability mark. Future policy benefits dropped 4.5%, from $62,320 million to $59,519 million, and the AOCI line "effect of changes in discount rate assumptions" rose from $8,035 million to $9,458 million. Under LDTI, higher discount rates cut the carrying value of long-duration reserves at the same time they cut bond values — the two largely cancel. Investors reading only the asset side would badly misjudge this balance sheet.
One line moved sharply and is worth naming: payables for return of cash collateral on loaned securities jumped 60.8%, from $3,989 million to $6,414 million. This is securities lending activity, not operating leverage, and it inflates both sides of the balance sheet without adding economic risk in the ordinary case — but it is a $2.4 billion swing in a quarter and explains why total liabilities barely fell despite a $2.8 billion reduction in policy liabilities.
1-2. Financial versus operating liabilities
Notes payable and lease obligations fell 6.0%, from $8,409 million to $7,908 million, driven by $400 million of principal repayment in the quarter plus currency effects. Against $29,961 million of shareholders' equity, financial leverage is modest for a life and health insurer. Total policy liabilities — the operating side — fell from $69,583 million to $66,782 million, almost entirely the discount-rate effect described above rather than any reduction in obligations to policyholders.
1-3. Capital structure
The equity account tells the most striking story in the filing. Retained earnings stand at $55,702 million, up $1,020 million on the quarter's earnings. Paid-in capital is just $3,064 million. And treasury stock, at average cost, is negative $30,842 million — meaning Aflac has spent more buying back its own stock over the years than the entire $29,961 million book value of the company today. Treasury stock grew $1,038 million this quarter alone. AOCI, at a positive $1,901 million, nets a $4,961 million cumulative foreign currency translation loss and a $2,665 million unrealized bond loss against the $9,458 million discount-rate benefit.
- Consolidated Statement of Earnings
2-1. Headline versus underlying
| Item | Q1 2025 ($M) | Q1 2026 ($M) | Change % |
|------|------------|------------|--------|
| Total revenues (GAAP) | 3,398 | 4,346 | +27.9% |
| Total adjusted revenues | 4,319 | 4,243 | -1.8% |
| Net investment gains (losses) | (963) | 49 | — |
| Pretax adjusted earnings | 1,123 | 1,122 | -0.1% |
| Earnings before income taxes | 145 | 1,225 | +744.8% |
| Net earnings | 29 | 1,019 | +3,414% |
| Diluted EPS ($) | 0.05 | 1.98 | +3,860% |
Adjusted revenues here exclude net investment gains and losses but reclassify amortized hedge costs and derivative net interest into adjusted net investment income; adjusted expenses exclude non-recurring items outside normal insurance operations. On that basis revenue fell 1.8% while GAAP revenue rose 27.9%. Anyone anchoring on the GAAP top line is reading a derivatives and bond-mark number, not a business.
The tax line is its own oddity. Q1 2025 carried $116 million of tax on $145 million of pretax earnings — an 80% effective rate that crushed net earnings to $29 million and created the artificially low base every percentage comparison now runs against. Q1 2026's total effective rate was 16.8% ($206 million on $1,225 million) — below the 19.7% the company itself applies to pretax adjusted earnings ($221 million on $1,122 million), so the headline rate is flattered by items outside core operations rather than being a clean run-rate. Essentially all of the optical improvement in net earnings is the prior-year quarter's investment marks washing out — pretax adjusted earnings were flat at $1,122 million versus $1,123 million, and the $1,012 million swing in net investment gains accounts for 94% of the $1,080 million improvement in pretax earnings.
2-2. Segment performance
| Segment | Q1 2025 ($M) | Q1 2026 ($M) | Change % |
|------|------------|------------|--------|
| Japan — net earned premiums | 1,681 | 1,573 | -6.4% |
| Japan — adjusted revenue | 2,272 | 2,172 | -4.4% |
| Japan — pretax earnings | 722 | 759 | +5.1% |
| U.S. — net earned premiums | 1,502 | 1,555 | +3.5% |
| U.S. — adjusted revenue | 1,721 | 1,779 | +3.4% |
| U.S. — pretax earnings | 358 | 363 | +1.4% |
| Corporate and other — pretax | 43 | 0 | -100.0% |
A structural crossover is approaching. Japan's net earned premiums of $1,573 million are now barely ahead of the U.S. segment's $1,555 million — an $18 million gap that was $179 million a year ago — and Japan's share of total adjusted revenue slipped from 53% to 51%. Japan still holds 76% of consolidated assets ($88,446 million of $116,280 million), so the balance sheet remains a yen balance sheet even as the earnings mix Americanises.
Japan's premium decline is only partly currency: net earned premiums fell 3.8% in yen terms against the 6.4% decline in dollars, so roughly 2.6 percentage points is translation. But the company attributes the yen-basis decline mainly to a new external reinsurance transaction covering WAYS and Tsumitasu products as well as limited-pay policies reaching paid-up status, rather than broad lapse or runoff across the in-force block. Notably, the effect of foreign currency translation on after-tax adjusted earnings was just negative $8 million in both quarters. The yen is doing very little to earnings; it is the reinsurance transaction and paid-up dynamics that are compressing the premium line.
Yet Japan's pretax earnings rose 5.1% on falling revenue, because the benefit ratio improved materially: total benefits and claims of $990 million on $1,573 million of premium is 62.9%, against 65.7% a year ago. The U.S. moved the other way — benefits improved slightly to 47.2% from 47.7%, but adjusted expenses rose to $682 million from $647 million, taking the U.S. expense ratio to 43.9% from 43.1% and holding pretax growth to 1.4%.
2-3. The quality of the margin
Both segments booked favourable reserve remeasurement gains, and they doubled year over year: $45 million in Japan and $36 million in the U.S., $81 million combined, against $40 million in Q1 2025. That $41 million increment is 3.7% of pretax adjusted earnings. Strip the year-over-year improvement in remeasurement out and pretax adjusted earnings would have been roughly $1,081 million — down about 3.7% rather than flat. Reserve releases are legitimate earnings, but they are a judgment-driven, non-repeatable component of a benefit ratio, and this quarter they carried the margin.
- Cash Flow
| Item | Q1 2025 ($M) | Q1 2026 ($M) | Change |
|------|------------|------------|------|
| Operating activities | 589 | 968 | +64.3% |
| Investing activities | (359) | 244 | +603 |
| Financing activities | (1,261) | (1,762) | -501 |
| Effect of FX on cash | 33 | (41) | -74 |
| Ending cash | 5,231 | 5,654 | +8.1% |
Operating cash flow of $968 million against net earnings of $1,019 million gives an earnings-quality ratio of 0.95 — but that comparison is contaminated by the investment marks running through net earnings. Measured against after-tax adjusted earnings of roughly $901 million ($1,122 million pretax less $221 million of tax applicable to adjusted earnings), the ratio is a healthier 1.07. The $379 million year-over-year improvement in operating cash came mainly from policy liabilities swinging to a $519 million source of cash from a $136 million use.
Free cash flow is not a meaningful construct for an insurer. The relevant test is whether distributable cash covers capital returns, and here the answer is no — not this quarter. Aflac spent $1,000 million on treasury stock purchases and paid $304 million in dividends, $1,304 million of capital returned against $968 million of operating cash flow and roughly $901 million of after-tax adjusted earnings. That is a payout of about 145% of underlying earnings, funded by the $244 million investing inflow and the cash balance, which fell 9.5%. The company simultaneously retired $400 million of debt. This is deliberate balance-sheet deployment by a company with excess capital, not distress — but it is not self-funding at this rate.
- What Else Matters
The share count is doing the work. Diluted weighted-average shares fell from 546.878 million to 514.785 million, down 5.9% year over year. Held flat, the same $1,019 million of net earnings would have produced EPS of $1.86 rather than $1.98 — the buyback contributed roughly $0.12, about 6% of reported EPS. Over a longer window the effect compounds against a shrinking revenue base, which is the central tension in this name.
Premiums have declined for three straight years. Consolidated net earned premiums by first quarter, per SEC XBRL data: $3,688 million (2023), $3,456 million (2024), $3,381 million (2025), $3,310 million (2026) — a 10.2% contraction over three years and down 2.1% this quarter. Aflac Japan reported first-quarter sales up 25.5%, driven by its Onsen Tallett medical and Miraito cancer products, but new sales are not yet replacing the runoff: underlying earned premiums excluding reinsurance, paid-up policies and deferred profit liability still declined 1.3%. The gap between strong sales momentum and a shrinking in-force block is the number to track over the next several quarters.
Credit is deteriorating at the margin. The total allowance for credit losses rose from $446 million to $474 million in the quarter, with a $47 million addition against $19 million of net writeoffs. Within that, the middle market loans allowance rose 18.1%, from $138 million to $163 million, and transitional real estate loans from $277 million to $286 million. The balance sheet allowance against commercial mortgage and other loans rose to $457 million from $426 million — about 4.5% of the gross book. Aflac separately identified transitional real estate loans with $139 million of amortized cost in anticipation of potential foreclosure or deed-in-lieu transactions, against which it holds a $61 million allowance. These are small numbers relative to $116 billion of assets, but the direction is consistent and worth monitoring.
The Japan bond book is safer than it looks. Of the $15,752 million held-to-maturity portfolio, $15.0 billion is Japan Government and Agency securities carrying a zero-credit-loss expectation and excluded from allowance measurement. The $983 million unrecognized loss on that book is interest-rate driven, not credit driven, and reverses toward par at maturity.
Internal reinsurance. Aflac Re, the Bermuda-domiciled internal reinsurer reported in Corporate and other, recorded $158 million of net earned premiums from Aflac Japan versus $178 million a year ago. These transactions have no consolidated financial statement impact except for foreign currency accounting effects, but they do reduce reported Japan segment premiums — a reconciliation point when comparing segment disclosures across periods.
Note 13 on commitments and contingent liabilities and Item 2 MD&A fall outside the extracted portion of this filing, so litigation exposure, solvency margin ratio and ESR capital metrics are not addressed in this analysis.
- Key Takeaways and Outlook
What grew. Not much, on an underlying basis. The U.S. segment delivered genuine premium growth of 3.5% and Japan's benefit ratio improved by 2.8 percentage points to 62.9%, lifting Japan pretax earnings 5.1% on a shrinking revenue line. Japan's new-business sales momentum of 25.5% is real and is the most encouraging forward indicator in the quarter. Operating cash flow rose 64.3%.
What is at risk. The premium base has contracted for three consecutive years and is now 10.2% below its Q1 2023 level. Pretax adjusted earnings were flat, and even that flat result leaned on $81 million of favourable reserve remeasurement that doubled year over year — without the increment, underlying earnings would have declined roughly 3.7%. U.S. expenses are growing faster than U.S. premiums, pushing the expense ratio to 43.9%. Roughly $3.2 billion of unrealized investment losses sit in AOCI or unrecognized on the HTM book ($2,228 million net across the full AFS book plus $983 million unrecognized on HTM), hedged economically by the discount-rate benefit on reserves but exposed if rates reverse. And credit provisioning on middle market and transitional real estate loans is building.
Capital allocation. This is the clearest signal in the filing. Aflac returned $1,304 million to shareholders in a quarter that produced roughly $901 million of underlying after-tax earnings, retired $400 million of debt, and reallocated $1.3 billion into higher-yielding alternative investments. Cumulative treasury stock at cost now exceeds total book equity. Management is explicitly running a shrink-the-equity strategy: if revenue cannot grow, reduce the share count faster than the premium base declines and per-share metrics still rise.
That arithmetic works while excess capital lasts and while the Japan runoff stays gradual. It stops working if the buyback has to slow, or if Japan's new sales fail to close the gap with the paid-up and lapsing block. For now the equity story is a capital-return story, and the operating story is one of a business holding its margin while its top line erodes. The two are not the same thing, and this quarter's $1.98 EPS conceals rather than reveals that distinction.
Disclaimer
This analysis is based on filings submitted to the U.S. Securities and Exchange Commission and is provided for informational purposes only. It is not investment advice. Source: SEC Form 10-Q, filed May 6, 2026.
